Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 7, 2021 | METiS Therapeutics | $86.0M Series A | China Life, People's Insurance Company of China | 5Y Capital, Hongshan Capital Group (Sequoia Capital China), Lightspeed Venture Partners |